Zhu reported that a MYC-responsive lncRNA called gLINC enhances cancer glycolysis and tumor formation by assembling glycolytic enzymes such as ENO1 and PGK1, PKM2, and LDHA (Fig. 4C) [73]. The gene discussed is MYC; the disease is neoplasm.